by Limitless Consulting

See the signals. Move with intelligence.

BioSignalIQ is an AI-powered commercial intelligence platform built for life-science leaders — continuously monitoring competitors, markets, clinical evidence, capital activity, and commercial developments.

Limited initial availability · $1,500/month · 90-day pilot

What BioSignalIQ Monitors

COMPETITORS

Product launches, strategic moves, leadership changes and commercial activity.

MARKETS

Emerging applications, market shifts and geographic expansion.

CUSTOMERS

Publicly available adoption, validation, collaborations and institutional activity.

TECHNOLOGY

Publications, clinical evidence, patents and technology developments.

CAPITAL

Financings, SEC filings, M&A and other material financial events.

PEOPLE

Executive appointments, commercial hiring and organizational changes.

From Information to Intelligence

BioSignalIQ doesn't simply aggregate news. Our intelligence engine identifies meaningful developments, verifies them against primary sources, organizes them into structured commercial signals and analyzes why they may matter.

WHAT HAPPENED?

The verified development — confirmed against primary sources before it enters the intelligence record.

WHY DOES IT MATTER?

The potential commercial significance — analyzed in the context of your competitive landscape.

WHAT SHOULD YOU WATCH?

Developments that may provide additional evidence or change the interpretation of the signal.

Weekly Intelligence

BioSignalIQ Executive Brief

A concise weekly intelligence briefing customized around the companies, technologies and markets that matter to your organization.

Designed to be read in approximately five minutes.

Competitive Movement·Commercial Signals·Technology·Clinical Evidence·Capital·What We're Watching

Intelligence on Demand

Ask BioSignalIQ

Turn months of competitive intelligence into answers.

What has changed at Company X during the past six months?

Show recent evidence of European commercial expansion.

Which competitors are gaining traction in hematologic malignancies?

What significant commercial signals appeared this month?

Answers are grounded in BioSignalIQ's continuously updated intelligence database and linked to underlying sources.

Founding Partner Program

Founding Partner Program

$1,500/month· 90-day pilot

  • Up to 10 tracked competitors
  • Customized intelligence monitoring
  • Material competitive alerts
  • Weekly Executive Intelligence Brief
  • Ask BioSignalIQ access
  • Custom intelligence requests

Limited initial availability.

BioSignalIQ

by Limitless Consulting

See the signals. Move with intelligence.

© 2026 BioSignalIQ by Limitless Consulting. All rights reserved.